Orexo AB ( Orexo AB)

Primary tabs

Orexo AB's picture

Management

Contact Address

About Orexo AB

Orexo is a pharmaceutical company based in Uppsala, Sweden initially financed with venture capital provided by HealthCap.

Orexo AB press release, blog etc

Wed, 07/10/2024 - 23:15 Orexo ABs sustainability work ranked among top 5% by EcoVadis
Fri, 10/28/2022 - 02:31 Orexo announces last patient enrolled in pivotal study evaluating the efficacy of MODIA in combination with sublingual buprenorphine/ naloxone for the treatment of OUD
Wed, 12/22/2021 - 01:32 Robert Ronn, SVP and Head of R&D: My vision is to develop several new drugs based on amorphOX
Thu, 12/02/2021 - 03:36 Orexo develops a nasal adrenaline medication based on the novel amorphOX platform
Mon, 11/01/2021 - 00:52 Orexos Nomination Committee for the Annual General Meeting 2022
Mon, 10/18/2021 - 10:09 MODIA paper published in the Journal of Medical Internet Research Mental Health
Fri, 07/16/2021 - 07:06 Orexos flagship pharmaceutical pipeline asset OX124 enters pivotal trial
Mon, 07/12/2021 - 07:03 Sober Grid Users to Gain Access to Clinically Proven Digital Therapeutics Through New Commercial Partnership with Orexo
Mon, 07/12/2021 - 06:27 Orexo signs commercial partnership agreement with Sober Grid allowing community users access to clinically proven digital therapies vorvida and deprexis
Thu, 07/01/2021 - 05:12 Orexo announces first patient enrolled in pivotal study evaluating the efficacy of modia in combination with sublingual buprenorphine/ naloxone for the treatment of OUD
Wed, 06/02/2021 - 06:59 Orexo continues to strengthen ZUBSOLVs patent portfolio with two new patents
Tue, 05/18/2021 - 04:40 Orexo and Lyfebulb Partner During Unprecedented Times to Help Those Struggling with Alcohol and Opioid Use Disorders
Wed, 03/17/2021 - 07:05 Orexo continues to strengthen IP rights for ZUBSOLV
Mon, 02/17/2020 - 02:40 Orexo AB (publ.) has resolved to carry out repurchases of own shares
Wed, 01/29/2020 - 21:12 Q4 incl. Full Year Report 2019
Thu, 10/24/2019 - 20:28 Orexo Interim Report Q3 2019
Fri, 10/18/2019 - 15:54 A specialty pharmaceutical company with the aim of becoming a leader within treatment of addiction
Fri, 10/11/2019 - 14:49 A specialty pharmaceutical company with the aim of becoming a leader within addiction
more

InfoBox

HomePagewww.orexo.com
Twittertwitter.com/OrexoABpubl
LinkedInwww.linkedin.com/company/65006
Wikipediaen.wikipedia.org/wiki/Orexo